Euro
USD
British Pound
NULL
![NCI-H209 [H209] cell line](https://cdn11.bigcommerce.com/s-452hpg8iuh/images/stencil/1280x1280/products/904920/1197121/elabscience__13538.1643193164__44410.1643194172__90041.1647951641__90987.1664298234.png?c=2 "NCI-H209 [H209] cell line")
![NCI-H209 [H209] cell line](https://cdn11.bigcommerce.com/s-452hpg8iuh/images/stencil/100x100/products/904920/1197121/elabscience__13538.1643193164__44410.1643194172__90041.1647951641__90987.1664298234.png?c=2 "NCI-H209 [H209] cell line")
Product Description
NCI-H209 [H209] cell line | EP-CL-0393 | Elabscience
Background: This cell line was established in 1979 from the bone marrow aspirated of a 55-year-old male Caucasian with small cell lung carcinoma prior to treatment. The line is a classic small cell lung carcinoma cell line that expresses four biochemical markers, i.e., neuron specific enolase, brain isoenzyme of creatine kinase, L-DOPA decarboxylase and bombesin-like immunoreactivity.
Species: Homo sapiens, Human
Age: 55 years
Tissue: Lung; Originating From Metastatic Site: Bone Marrow
Morphology: Round Cell Clusters
Growth Properties: Suspension
Organism: Homo sapiens, Human
Species Cell: Human
application: N/A
Doubling Time: ~50-70 hours
Biosafety: 1
Subculturing: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at the subcultivation ratio of 1:2-1:3.
Ratio: 1: 2-1: 3
Renewal: 2-3 times per week
![NCI-H209 [H209] cell line](https://cdn11.bigcommerce.com/s-452hpg8iuh/images/stencil/500x659/products/904920/1197121/elabscience__13538.1643193164__44410.1643194172__90041.1647951641__90987.1664298234.png?c=2 "NCI-H209 [H209] cell line")
![NCI-H209 [H209] Cells Complete Medium](https://cdn11.bigcommerce.com/s-452hpg8iuh/images/stencil/500x659/products/450738/653820/elabscience__13538.1643193164__44410.1643194172__75345.1648028240.png?c=2 "NCI-H209 [H209] Cells Complete Medium")
